Patents by Inventor Bjoern Schlummer

Bjoern Schlummer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9630955
    Abstract: There is disclosed a methylated intermediate which may be demethylated to provide an inhibitor of catechol-O-methyltransferase useful in the treatment of Parkinson's disease. Also disclosed are methods of making and using said intermediate.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: April 25, 2017
    Inventors: Domenico Russo, Laszlo Erno Kiss, Jorge Bruno Reis Wahnon, David Alexander Learmonth, Tibor Eszenyi, Axel Zimmermann, Bjoern Schlummer, Michael Kreis, Klaus Reiter
  • Publication number: 20160043437
    Abstract: The present invention relates to pure lithium hexafluorophosphate and its use in an electrolyte and also a process for reducing the content of fluoride in lithium hexafluorophosphate.
    Type: Application
    Filed: April 10, 2014
    Publication date: February 11, 2016
    Applicant: LANXESS Deutschland GmbH
    Inventors: Matthias BOLL, Wolfgang EBENBECK, Bjoern SCHLUMMER
  • Publication number: 20160009700
    Abstract: There is disclosed a methylated intermediate which may be demethylated to provide an inhibitor of catechol-O-methyltransferase useful in the treatment of Parkinson's disease. Also disclosed are methods of making and using said intermediate.
    Type: Application
    Filed: July 31, 2015
    Publication date: January 14, 2016
    Inventors: Domenico Russo, Laszlo Erno Kiss, Jorge Bruno Reis Wahnon, David Alexander Learmonth, Tibor Eszenyi, Axel Zimmermann, Bjoern Schlummer, Michael Kreis, Klaus Reiter
  • Patent number: 9126988
    Abstract: There is disclosed a methylated intermediate which may be demethylated to provide an inhibitor of catechol-O-methyltransferase useful in the treatment of Parkinson's disease. Also disclosed are methods of making and using said intermediate.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: September 8, 2015
    Assignee: BIAL—PORTELA & CA, S.A.
    Inventors: Domenico Russo, Laszlo Erno Kiss, Jorge Bruno Reis Wahnon, David Alexander Learmonth, Tibor Eszenyi, Axel Zimmermann, Bjoern Schlummer, Michael Kreis, Klaus Reiter
  • Publication number: 20140350057
    Abstract: There is disclosed a methylated intermediate which may be demethylated to provide an inhibitor of catechol-O-methyltransferase useful in the treatment of Parkinson's disease. Also disclosed are methods of making and using said intermediate.
    Type: Application
    Filed: December 12, 2012
    Publication date: November 27, 2014
    Applicant: BIAL - PORTELA & CA, S.A.
    Inventors: Domenico Russo, Laszlo Erno Kiss, Jorge Bruno Reis Wahnon, David Alexander Learmonth, Tibor Eszenyi, Axel Zimmermann, Bjoern Schlummer, Michael Kreis, Klaus Reiter
  • Publication number: 20080207907
    Abstract: The invention relates to a novel process for the Pd catalysed formation of C—N bonds between an aryl halide or an aryloxysulphonyl compound and an amine in specific solvent systems, and also to the use of these solvent systems for C—N couplings.
    Type: Application
    Filed: November 23, 2005
    Publication date: August 28, 2008
    Applicant: UCB PHARMA, S.A.
    Inventors: Björn Schlummer, Ulrich Scholz, Ian Smith
  • Patent number: 7396964
    Abstract: The present invention relates to a process for preparing enantiomerically enriched 2-butanol and to its use.
    Type: Grant
    Filed: September 2, 2004
    Date of Patent: July 8, 2008
    Assignee: LANXESS Deutschland GmbH
    Inventors: Björn Schlummer, Martin Stürmann
  • Patent number: 7329779
    Abstract: The present invention relates to a process for preparing optionally substituted arylsulphonic anhydrides of the general formula (I)
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: February 12, 2008
    Assignee: LANXESS Deutschland GmbH
    Inventors: Björn Schlummer, Florian Rampf, Paul Naab, Guido Giffels, Matthias Gotta
  • Patent number: 7193102
    Abstract: By means of a new process for the resolution of racemic 3-aminopentanenitrile, enantiomerically enriched 3-aminopentanenitrile or its salts can be obtained. For this, racemic 3-aminopentanenitrile is reacted with an enantiomerically enriched organic acid and one of the two diastereomeric salts formed is separated off and then converted into the enantiomerically enriched 3-aminopentanenitrile or its salts.
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: March 20, 2007
    Assignee: Bayer Aktiengesellschaft
    Inventors: Claus Dreisbach, Björn Schlummer